Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Biomx inc. exchanges : Amex save search
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
Published: 2024-04-04 (Crawled : 12:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 11.43%
H: 0.0%
C: -2.56%
guidelines
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-03 (Crawled : 11:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 6.72%
H: 2.44%
C: -14.63%
business year update financial results
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
Published: 2024-03-27 (Crawled : 11:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 1.28%
H: 5.88%
C: 4.73%
conference year financial results
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
Published: 2024-03-18 (Crawled : 11:00) - globenewswire.com
PPRUF | $368.87 610
|
Consumer Non-Durables
|
| O: -0.49%
H: 2.65%
C: 2.65%
PPRUY | $36.825 310K
|
Manufacturing
|
| O: -0.43%
H: 0.02%
C: -0.5%
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 1.09%
H: 3.38%
C: -2.7%
million acquisition therapeutics
Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to account for 41% of market growth, Technavio
Published: 2024-03-06 (Crawled : 15:30) - prnewswire.com
PTCHF | $2.78 560
|
n/a
|
| O: 4.12%
H: 0.97%
C: 0.97%
FNCH | $2.33 3.79% 39K
|
Professional, Scientific, and T...
|
| O: -4.0%
H: 4.92%
C: 4.12%
EVGN | $0.6863 27K
|
Health Technology
|
| O: 4.24%
H: 0.0%
C: -7.14%
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 211.55%
H: 18.75%
C: -4.46%
america million therapeutics market
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
Published: 2024-03-06 (Crawled : 12:30) - globenewswire.com
PPRUF | $368.87 610
|
Consumer Non-Durables
|
| O: 1.5%
H: 1.23%
C: 1.05%
PPRUY | $36.825 310K
|
Manufacturing
|
| O: 0.81%
H: 0.22%
C: -0.18%
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 211.55%
H: 18.75%
C: -4.46%
million therapeutics agreement
Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to account for 41% of market growth - Technavio
Published: 2024-01-08 (Crawled : 10:00) - prnewswire.com
PTCHF | $2.78 560
|
n/a
|
| O: 3.67%
H: 0.19%
C: 0.19%
FNCH | $2.33 3.79% 39K
|
Professional, Scientific, and T...
|
| O: 6.09%
H: 3.01%
C: -4.37%
EVGN | $0.6863 27K
|
Health Technology
|
| O: -6.76%
H: 3.38%
C: 0.3%
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: -3.15%
america million therapeutics growth market
BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis
Published: 2024-01-04 (Crawled : 13:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: -0.37%
H: 6.26%
C: 0.04%
bx004 drug food infection treatment fibrosis designation
BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 5.4%
H: 3.26%
C: -18.09%
bx004 review positive fibrosis infections trial results
BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis
Published: 2023-11-29 (Crawled : 12:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: -30.36%
H: 14.21%
C: -23.08%
bx004 positive treatment fibrosis topline infections trial results
BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: -2.59%
H: 5.26%
C: 1.42%
business update financial results
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conference
Published: 2023-10-27 (Crawled : 12:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 11.07%
H: 0.0%
C: -8.33%
bx004 conference treatment ongoing fibrosis infections study
BiomX Announces the Appointment of Edward L. Williams to its Board of Directors
Published: 2023-10-18 (Crawled : 12:00) - globenewswire.com
BCAB | $2.76 -3.5% 200K
|
|
| O: -1.67%
H: 1.41%
C: 0.0%
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: -0.03%
H: 9.68%
C: 4.03%
Atopic Dermatitis Drugs Market to grow by USD 4.7 billion from 2022-2027 | North America to account for 36% of market growth- Technavio
Published: 2023-10-17 (Crawled : 05:00) - prnewswire.com
ALPMY | $9.2715 500K
|
Manufacturing
|
| O: -0.27%
H: 1.38%
C: 0.83%
VTRS | $11.145 -1.55% 1.1M
|
Health Technology
|
| O: -0.95%
H: 1.81%
C: 0.53%
NVS | $93.07 -1.42% 280K
|
Health Technology
|
| O: 0.2%
H: 0.44%
C: -0.56%
ABBV | $163.45 1.1% 1.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
SNY | $46.2 0.59% 210K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 5.0%
H: 3.17%
C: -1.56%
america dermatitis market
BiomX Announces Completion of Patient Dosing in Part 2 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis
Published: 2023-10-04 (Crawled : 11:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 2.86%
H: 0.0%
C: -0.03%
bx004 treatment fibrosis infections study
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections
Published: 2023-09-07 (Crawled : 14:30) - biospace.com/
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: -1.03%
H: 1.55%
C: 1.04%
bx004 treatment ongoing infections study
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023
Published: 2023-09-07 (Crawled : 13:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: -1.03%
H: 1.55%
C: 1.04%
bx004 congress respiratory international treatment ongoing fibrosis infections study
BiomX to Present at H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-06 (Crawled : 20:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: -1.03%
H: 1.55%
C: 1.04%
conference global
BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-09 (Crawled : 11:00) - globenewswire.com
BIIB | $196.8 170K
|
Health Technology
|
| O: -0.23%
H: 0.78%
C: -0.81%
AMRN | $0.9154 -0.35% 210K
|
Health Technology
|
| O: -0.43%
H: 0.87%
C: 0.87%
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 4.86%
H: 0.0%
C: -13.5%
business update financial results
BiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023
Published: 2023-08-02 (Crawled : 20:00) - globenewswire.com
PHGE | $0.2923 -2.6% 33K
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: -2.34%
conference financial results
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
TPET | $0.503 117.66% 21M
|
n/a
JAGX | $0.23 93.6% 310M
|
Health Technology
WISA 4 | $3.22 84.0% 56M
|
Electronic Technology
SXTC | $2.56 82.86% 11M
|
Health Technology
PALI | $6.57 57.93% 19M
|
Manufacturing
DYNT | $0.5255 41.87% 18M
|
Health Technology
PRSO | $1.79 40.95% 38M
|
Manufacturing
MCBC | $13.755 38.52% 620K
|
Finance
BTTR | $6.86 34.51% 5.2M
|
Manufacturing
SNGX | $0.51 32.09% 6.3M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.